Banca Mediolanum S.p.A. BMED.MI
Banca Mediolanum S.p.A. (BMED.MI) earns a Piotroski F-score of 4/9 (mixed financial health). It pays a dividend yielding 5.65% (safety: stretched). FY2025 revenue was $2.4B at a 50.7% net margin.
Price from month-end closes (Yahoo) — for reference, not real-time.
How it ranks in Financial Services · percentile among 50 companies
Percentile vs other Financial Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 4/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
FAQ
Is BMED.MI financially healthy?
Banca Mediolanum S.p.A.'s Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak).
Does BMED.MI pay a dividend, and is it safe?
Yes. Banca Mediolanum S.p.A. pays a dividend yielding about 5.65% with a 73.4% payout ratio, rated “stretched” for safety.
How profitable is BMED.MI?
In FY2025, Banca Mediolanum S.p.A. had a net margin of 50.7% and a return on equity of 27.5%.
Source: company filings via Yahoo Finance · IT · as of 2025-12-31. Figures in EUR; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.